Safety and Tolerability of Solifenacin Add-on Therapy to α-Blocker Treated Men With Residual Urgency and Frequency
Author:
Affiliation:
1. Weill Medical College of Cornell University, New York, New York
2. Eastern Virginia Medical School, Norfolk, Virginia
3. Deaconess Medical Building, Spokane, Washington
4. Astellas Pharma US Inc., Deerfield, Illinois
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference22 articles.
1. The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society;Abrams;Urology,2003
2. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder;Chapple;Eur Urol,2006
3. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms;Lemack;Nat Clin Pract Urol,2007
4. Antimuscarinic therapy in men with lower urinary tract symptoms: what is the evidence?;Dmochowski;Curr Urol Rep,2006
5. BPH with coexisting overactive bladder dysfunction–an everyday urological dilemma;Knutson;Neurourol Urodyn,2001
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and efficacy of an α1‐blocker plus mirabegron compared with an α1‐blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta‐analysis;Neurourology and Urodynamics;2024-01-30
2. Incontinencia urinaria;Actualización en Medicina de Familia;2023-09-01
3. Summary Paper on the 2023 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms;European Urology;2023-08
4. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14
5. Treating overactive bladder symptoms after transurethral prostatic surgery for benign prostatic hyperplasia – Which medication to choose?;Tzu Chi Medical Journal;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3